关于Certara
Certara 致力于通过生物模拟软件、技术和服务加速药物研发,改变传统的药物研发方式。其客户包括超 2,400 家生物制药公司、学术机构和来自 70 个国家的监管机构。了解更多信息,请访问 www.certara.com.cn。
Investor Relations Contact:
David Deuchler
Gilmartin Group
[email protected]
媒体联系人:
Alyssa Horowitz
[email protected]
Home / Press Release / Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025
Radnor, Pa. — 2025 年 10 月 10 日 — Certara, Inc. (纳斯达克股票代码:CERT), a global leader in model-informed drug development, today announced that it will release financial results for the third quarter of 2025 after the market close on Thursday, November 6th, 2025. Company management will host a conference call to discuss financial results at 5:00PM ET.
Investors interested in listening to the conference call are required to register online. It is recommended to register at least one day in advance.
A live and archived webcast of the event will be available on the “Investors” section of the Certara website at https://ir.certara.com/.
Certara 致力于通过生物模拟软件、技术和服务加速药物研发,改变传统的药物研发方式。其客户包括超 2,400 家生物制药公司、学术机构和来自 70 个国家的监管机构。了解更多信息,请访问 www.certara.com.cn。
David Deuchler
Gilmartin Group
[email protected]
Alyssa Horowitz
[email protected]
